At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- AtriCure Cryo Nerve Block (cryoNB) Device Family (device)
- How long the study runs
- Study runs about 259 months (dates as stated)
- About the drug or intervention
- AtriCure Cryo Nerve Block (cryoNB) Device Family — device: Use of Atricure Cryo Nerve Block Device Family to generate cryoanalgesia for the management of post operative pain.
- Patient visit burden
- Not specified by the sponsor
In plain English
This registry study collects information on results from cryoanalgesia of the intercostal nerves, a treatment using extreme cold to numb nerves in the chest wall, for pain after surgery. It is run across several centres and sponsored by AtriCure, Inc.
Who can take part
- Age 12 or above, and able to agree to take part (with consent or assent as required by law)
- Scheduled by a doctor to have, or already had, freezing treatment (cryoablation) of the intercostal nerves using at least one AtriCure device, or are similar patients treated without cryoablation
Who may not be able to
- Taking part in another study that could affect the treatment given with the devices in this registry
- Meeting any exclusion rules set by local governance
- Women who could become pregnant and are pregnant or planning pregnancy during the study
What taking part involves
- • Cryoablation (freezing) of the intercostal nerves using at least one AtriCure device
- • Some similar patients are treated without cryoablation for comparison
Time commitment: Not stated — ask the trial team.
Plain-English summary (AI-generated) from registry data. Not eligibility advice — only the trial team can confirm whether you can take part. Use the eligibility checker to see how your health profile matches this trial.
- Type of study
- Observing health over time
- Ages
- 12 Years and over
- Who
- All
- Number of participants
- 5,000
- Started
- 2018-06-29
- Last checked
- 2026-06
Plain English Summary
What is this study?
- • Testing a new treatment for post operative pain
- • Clinical study - 5,000 participants
- • This is a retrospective and prospective, multicenter, observational patient registry to record outcomes from patients undergoing cryoablation of the intercostal nerves (cryoanalgesia) for post-operative pain management
Who can take part?
- • Ages 12 Years and over
- • Diagnosed with post operative pain
Where?
- • Leicester - University Hospitals Leicester NHS Trust
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
This is a retrospective and prospective, multicenter, observational patient registry to record outcomes from patients undergoing cryoablation of the intercostal nerves (cryoanalgesia) for post-operative pain management.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 12 Years and over
- Who can join: All genders
What the study is looking for
- ✓Patients whose age is 12 years or above, and are able to give agreement to take part/assent specific to state and national...
Who cannot take part
- ✗Patient is enrolled in a concurrent trial that may impact the treatment offered by the registry devices.
- ✗Patient with exclusion criteria required by local governance.
- ✗Women of childbearing potential who are, or plan to become, pregnant during the time of the study
See the full criteria
Where Is This Study? (1 UK site)
University Hospitals Leicester NHS Trust
Leicester, United Kingdom
How to Get in Touch
Elizabeth Menard
Sponsor contactCONTACT
Laura O'Brien, PhD
Sponsor contactCONTACT